Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.

Maarouf, Chera L; Beach, Thomas G; Adler, Charles H; Shill, Holly A; Sabbagh, Marwan N; Wu, Terence; Walker, Douglas G; Kokjohn, Tyler A; Roher, Alex E

Maarouf, Chera L; Beach, Thomas G; Adler, Charles H; Shill, Holly A; Sabbagh, Marwan N; Wu, Terence; Walker, Douglas G; Kokjohn, Tyler A; Roher, Alex E.

Affiliation

Maarouf CL; The Longtine Center for Neurodegenerative Biochemistry, Banner Sun Health Research Institute, Sun City, AZ, USA.

Neurol Res ; 34(7): 669-76, 2012 Sep.

Article in En | MEDLINE | ID: mdl-22889670

Subject(s)

Parkinson Disease/cerebrospinal fluid; Parkinson Disease/diagnosis; Aged; Aged, 80 and over; Apolipoprotein A-I/cerebrospinal fluid; Apolipoproteins E/cerebrospinal fluid; Biomarkers/cerebrospinal fluid; Clusterin/cerebrospinal fluid; Cohort Studies; Female; Fibrinogen/cerebrospinal fluid; Glutathione S-Transferase pi/cerebrospinal fluid; Humans; Male; Middle Aged; Parkinson Disease/pathology; Prealbumin/cerebrospinal fluid; Protein Isoforms/cerebrospinal fluid; Two-Dimensional Difference Gel Electrophoresis/methods

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neurol Res Year: 2012 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google